[{"id":"41000dfd-c03d-4b57-8024-e57a425d66f4","acronym":"","url":"https://clinicaltrials.gov/study/NCT01213472","created_at":"2021-01-18T04:52:16.779Z","updated_at":"2024-07-02T16:36:54.740Z","phase":"Phase 1","brief_title":"Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma","source_id_and_acronym":"NCT01213472","lead_sponsor":"GlaxoSmithKline","biomarkers":" CTAG1B","pipe":" | ","alterations":" CTAG1B expression","tags":["CTAG1B"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CTAG1B expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GSK2241658A"],"overall_status":"Completed","enrollment":" Enrollment 33","initiation":"Initiation: 01/31/2011","start_date":" 01/31/2011","primary_txt":" Primary completion: 04/17/2018","primary_completion_date":" 04/17/2018","study_txt":" Completion: 04/17/2018","study_completion_date":" 04/17/2018","last_update_posted":"2019-10-09"}]